Tendinopathy Relief With Ultrasound-Guided Care Methods

Percutaneous Tenotomy and Ultrasound-Guided Tendon Debridement: A Modern, Evidence-Based Approach to Tendinopathy Management

Abstract

Tendinopathy is one of the most common musculoskeletal complaints encountered in both primary care and integrative clinical settings. As treatment options evolve, percutaneous tenotomy has emerged as a powerful, minimally invasive, FDA-approved procedure that is now accessible to a broad range of healthcare providers. This educational post explores the physiological rationale behind tendon degeneration, the mechanisms behind ultrasound-guided percutaneous tenotomy using devices such as Tenex and TenJet, the clinical indications currently approved for this procedure, and how this advanced technique fits into a comprehensive, multidisciplinary care model. At Injury Medical Clinic PA in El Paso, Texas, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, collaborate to deliver exactly this kind of integrative, patient-centered care—combining chiropractic expertise, medical oversight, functional medicine, and the latest evidence-based interventional techniques to restore function and reduce pain.

Understanding Tendinopathy: The Physiological Foundation of Tendon Degeneration

Before appreciating why percutaneous tenotomy works, it is essential to understand what goes wrong inside a degenerated tendon at the cellular and structural level. Tendinopathy is not simply tendon inflammation—a long-standing misconception. Modern research has shifted away from the term “tendinitis” and toward “tendinopathy” because the dominant pathological process is degenerative, not purely inflammatory (Cook & Purdam, 2009).

At the histological level, a healthy tendon is composed primarily of type I collagen organized in parallel bundles, embedded in a proteoglycan-rich extracellular matrix, maintained by tenocytes. In tendinopathy, this organized architecture is replaced by:

• Disorganized collagen fibers with increased type III collagen deposition
• Neovascularization—the ingrowth of abnormal blood vessels accompanied by nociceptive nerve fibers, which contributes significantly to pain
• Mucoid and fibrinoid degeneration within the tendon matrix
• Calcific deposits in cases of calcific tendinopathy, where calcium hydroxyapatite crystals accumulate within the tendon substance
• Reduced mechanical load tolerance, leading to a cycle of micro-failure and failed healing

This failed healing response is driven by an imbalance between matrix metalloproteinases (MMPs) and their inhibitors, disrupting remodeling. The result is a tendon that is structurally compromised, pain-generating, and resistant to conservative therapies alone. This physiological understanding directly justifies procedures that mechanically remove degenerated tissue and stimulate a true healing response—which is precisely what percutaneous tenotomy accomplishes (Childress & Beutler, 2013).

What Is Percutaneous Tenotomy, and Why Is It Clinically Significant?

Percutaneous tenotomy is a minimally invasive, ultrasound-guided procedure designed to debride—meaning selectively remove—pathological, degenerated tendon tissue while preserving the surrounding healthy tissue. What makes this procedure particularly notable is that it is now firmly within the scope of primary care providers and integrative clinicians, not exclusively orthopedic surgeons.

Key clinical highlights of percutaneous tenotomy include:

• It is FDA-approved, including specifically for calcific tendinopathy
• It is performed under real-time ultrasound guidance, ensuring precision and safety
• It can be performed in an office or surgical suite setting, increasing accessibility
• It eliminates the need for open surgery in many cases of chronic tendinopathy
• It stimulates a biological healing response by creating controlled micro-trauma in the degenerated zone, recruiting growth factors, and initiating true tissue remodeling

The procedure shifts the treatment paradigm from passive management—rest, ice, anti-inflammatories, and physical therapy alone—toward active biological intervention. This approach is particularly meaningful for patients who have failed months of conservative care and face the prospect of surgery (Patel, 2021).

FDA-Approved Clinical Indications for Percutaneous Tenotomy

The currently approved indications for percutaneous tenotomy include some of the most common tendinopathic conditions seen in clinical practice. Understanding why clinicians target each site helps them identify appropriate candidates for referral or treatment.

Currently approved indications include:

• Extensor tendinopathy at the elbow—commonly known as “lateral epicondylitis” or “tennis elbow,” involving degeneration of the extensor carpi radialis brevis (ECRB) tendon at its humeral attachment
• Flexor tendinopathy at the elbow—”medial epicondylitis” or “golfer’s elbow,” involving the common flexor origin
• Patellar tendinopathy—”jumper’s knee,” a common condition in athletes involving the proximal patellar tendon
• Achilles tendinopathy—affecting either the mid-portion or insertional Achilles tendon
• Plantar fasciopathy—also known as plantar fasciitis, involving degeneration at the calcaneal attachment of the plantar fascia

Each site shares the same underlying pathophysiology of failed tendon healing and chronic degenerative change. In all cases, the degenerated tissue has lost its capacity for self-repair, making mechanical debridement and biological stimulation—the dual mechanism of percutaneous tenotomy—a logical, evidence-aligned intervention (Housner et al., 2009).

The Tenex System: Ultrasonic Emulsification and Vacuum Debridement

The Tenex device is one of two primary systems currently available for percutaneous tenotomy, and we use it in our clinical practice at Injury Medical Clinic PA. The underlying technology is both elegant and physiologically intelligent.

The Tenex system operates on the following principles:

• An ultrasonic vibrating needle tip generates high-frequency mechanical energy at the tip of an 18-gauge double-lumen needle
• This ultrasonic energy emulsifies—breaks down into fine particles—the degenerated tendon tissue with a high degree of selectivity, sparing healthy collagen
• A second lumen within the same needle system simultaneously suctions the emulsified debris out of the tissue, preventing local accumulation of degraded material
• The procedure is controlled by the provider via a foot pedal, allowing precise, real-time regulation of tissue cutting
• Cutting time for most tendinopathic procedures ranges from approximately 30 seconds to two minutes, depending on the extent of pathology

This dual-action mechanism — emulsify and evacuate — is conceptually borrowed from phacoemulsification, the same technique used in modern cataract surgery. The clinical genius of this crossover application is that it brings a highly refined, precision-tissue-removal technology into the musculoskeletal world. The needle is inserted under continuous real-time ultrasound guidance, with the probe maintained under sterile technique. The procedure is performed under full sterile conditions, and the ultrasound transducer itself is sheathed in a sterile cover to maintain asepsis throughout (Seng et al., 2016).

The TenJet System: High-Velocity Saline and Suction as an Alternative Approach

The second commercially available system for percutaneous tenotomy is TenJet, which employs a distinct but equally sound physiological strategy.

Key features of the TenJet system include:

• Uses a pressurized, high-velocity stream of saline directed at the degenerated tissue
• The mechanical force of the saline jet disrupts and removes pathological tissue
• Simultaneous suction evacuates the debris, similar to the Tenex model
• Offers an alternative debridement mechanism for providers or clinical scenarios where ultrasonic emulsification may not be the preferred approach
• May be particularly useful in certain calcific tendinopathy presentations where the calcium deposits require hydraulic disruption

Both systems aim to remove degenerative tissue and stimulate a healthy healing cascade by introducing controlled injury to a chronically failed healing zone, restarting the biological repair process the body has been unable to complete on its own (Patel, 2021).

Integrative Chiropractic Care and Percutaneous Tenotomy: The Multidisciplinary Advantage

At Injury Medical Clinic PA—also known as Mission Plaza Injury Medical Clinic—in El Paso, Texas, percutaneous tenotomy does not stand alone. It is integrated into a comprehensive, multidisciplinary treatment framework led by Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and supported by Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933), who serves as Medical Director and Collaborative Physician with over 40 years of experience as a board-certified internist.

This integrative model provides patients with layered, evidence-based care that addresses tendinopathy from multiple angles:

• Chiropractic care (Dr. Jimenez): Addresses biomechanical dysfunction in the spine, joints, and extremities that contributes to abnormal tendon loading patterns. Spinal and joint manipulation improves neuromuscular coordination, reduces compensatory movement patterns, and restores proper kinetic chain mechanics—all of which reduce recurrent stress on the affected tendon
• Medical oversight (Dr. Cardenas): Provides internal medicine expertise to evaluate systemic contributors to tendinopathy such as metabolic syndrome, diabetes, thyroid dysfunction, and dyslipidemia, all of which are known to impair tendon healing
• Functional medicine: Identifies and addresses nutritional deficiencies (such as vitamin D, magnesium, and collagen precursors), chronic inflammation, gut dysbiosis, and other root-cause factors that impair tissue repair
• Rehabilitation services: Structured eccentric loading programs and progressive tendon rehabilitation follow the procedure to consolidate the biological healing response and restore load-bearing capacity
• Personal injury care: For patients whose tendinopathy arose from workplace injuries, motor vehicle accidents, or other trauma, the clinic provides comprehensive documentation and coordinated care

As Dr. Jimenez has documented through his clinical observations, the most durable outcomes in tendinopathy management come not from any single intervention, but from addressing the whole patient—their biomechanics, biology, lifestyle, and healing environment simultaneously.

Why Ultrasound Guidance Is Non-Negotiable in Percutaneous Tenotomy

Real-time musculoskeletal ultrasound guidance is critical to the safety and efficacy of percutaneous tenotomy. This is not an optional enhancement—it is a foundational requirement.

Ultrasound guidance provides:

• Direct visualization of the needle tip at all times, preventing inadvertent injury to adjacent neurovascular structures
• Confirmation of needle placement within the zone of degeneration, ensuring debridement is targeted precisely
• Dynamic assessment of tissue response during the procedure
• The ability to identify and characterize calcific deposits, neovascularization, and tendon tears prior to and during the intervention
• Real-time feedback that allows the provider to adjust the needle trajectory as needed

Ultrasound guidance has transformed what was once a “blind” needling procedure into a precision intervention, dramatically improving safety profiles and clinical outcomes (Smith et al., 2017).

Clinical Outcomes and the Evidence Base Supporting Percutaneous Tenotomy

The evidence supporting percutaneous tenotomy continues to grow. Multiple prospective studies and clinical trials have demonstrated its effectiveness across the spectrum of approved indications.

Key evidence-based findings include:

• Significant reductions in Visual Analog Scale (VAS) pain scores in lateral epicondylitis patients following Tenex-guided debridement (Seng et al., 2016)
• Improved functional outcomes in Achilles and patellar tendinopathy measured by validated instruments such as the VISA-A and VISA-P scores
• High patient satisfaction rates with minimal downtime compared to open surgical alternatives
• Demonstrated superiority over corticosteroid injection for long-term pain relief in chronic tendinopathy, where corticosteroids offer only short-term palliation and risk tendon structural compromise with repeated use
• FDA clearance validating the safety and efficacy profile of the technology (Housner et al., 2009)

When combined with the biomechanical corrections and systemic health optimization provided by the integrative team at Injury Medical Clinic PA, these outcomes are further enhanced—reflecting the clinical philosophy that evidence-based procedural intervention and comprehensive integrative care produce superior results together than either does alone.

References

• Childress, M. A., & Beutler, A. (2013). Management of chronic tendon injuries. American Family Physician, 87(7), 486-490.
• Cook, J. L., & Purdam, C. R. (2009). Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. British Journal of Sports Medicine, 43(6), 409-416. doi.org/10.1136/bjsm.2008.051193
• Housner, J. A., Jacobson, J. A., Misko, R. (2009). Sonographically guided percutaneous needle tenotomy for the treatment of chronic tendinosis. Journal of Ultrasound in Medicine, 28(9), 1187-1192. doi.org/10.7863/jum.2009.28.9.1187
• Patel, M. M. (2021). A novel treatment approach for chronic tendinopathy with percutaneous ultrasonic tenotomy. Journal of Clinical Orthopaedics and Trauma, 12(1), 183-187. doi.org/10.1016/j.jcot.2020.09.030
• Seng, C., Mohan, P. C., Koh, S. B., Howe, T. S., Lim, Y. G., Lee, B. P., & Morrey, M. (2016). Ultrasonic percutaneous tenotomy for recalcitrant lateral elbow tendinopathy. The American Journal of Sports Medicine, 44(2), 504-510. doi.org/10.1177/0363546515612579
• Smith, J., Sellon, J. L., & Murthy, N. S. (2017). Ultrasound-guided procedures of the elbow. Physical Medicine and Rehabilitation Clinics of North America, 28(3), 487-510. doi.org/10.1016/j.pmr.2017.03.003